Trial Profile
A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Drospirenone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Leon Farma
- 07 Jul 2020 Results published in the Exeltis USA Media Release.
- 07 Jul 2020 According to a Exeltis USA media release, results from this study were published in Contraception.
- 13 Aug 2018 Status changed from active, no longer recruiting to completed.